SEC Form 4 · accession 0001144204-16-083939
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Doron
Director
Period of report
Feb 22, 2016
Accepted (ET)
Feb 23, 2016 · 8:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $1.89 | Feb 22, 2016 | A | 54,945 | A | May 22, 2016 | Feb 22, 2026 | Common Stock | 54,945 | 54,945 | D |
Explanation of responses
- F1The options were granted pursuant to the issuer's 2015 Equity Incentive Compensation Plan as compensation for additional director services rendered in connection with the issuer's reorganization. The options vest on a quarterly basis in eight equal installments, with the first installment vesting on May 22, 2016.